aluates Reports

$ 0.0

Automative

Neuroleptics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: September 2024

Report Code: QYRE-Auto-17F7193

Global Neuroleptics Market Insights and Forecast to 2028

BUY CHAPTERS

Neuroleptics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-17F7193

Report

September 2024

Pages:103

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Johnson & Johnson

Pfizer Inc

Eli Lilly

Bristol–Myers Squibb

Astrazeneca plc

GSK

Allergan plc

Neuroleptics - Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Neuroleptics - Market

Neuroleptics are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. They are increasingly being used in the management of non-psychotic disorders. Antipsychotics are usually effective in relieving symptoms of psychosis in the short term.

The global market for Neuroleptics was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neuroleptics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Neuroleptics by region & country, by Type, and by Application.

The Neuroleptics market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroleptics.

Market Segmentation

Scope of Neuroleptics - Market Report

Report Metric	Details
Report Name	Neuroleptics - Market
CAGR	5%
Segment by Type:	First Generation Second Generation Third Generation
Segment by Application	Schizophrenia Bipolar Disorder Unipolar Depression Dementia Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GSK, Allergan
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Neuroleptics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Neuroleptics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Neuroleptics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Neuroleptics - Market report?

Ans: The main players in the Neuroleptics - Market are Johnson & Johnson, Pfizer, Eli Lilly, Bristol-Myers Squibb, AstraZeneca, GSK, Allergan

What are the Application segmentation covered in the Neuroleptics - Market report?

Ans: The Applications covered in the Neuroleptics - Market report are Schizophrenia, Bipolar Disorder, Unipolar Depression, Dementia, Others

What are the Type segmentation covered in the Neuroleptics - Market report?

Ans: The Types covered in the Neuroleptics - Market report are First Generation, Second Generation, Third Generation

Recommended Reports

Mental Health Therapeutics

Neurology Pharmaceuticals

Clinical Disorder Treatment

1 Market Overview

1.1 Neuroleptics Product Introduction

1.2 Global Neuroleptics Market Size Forecast

1.2.1 Global Neuroleptics Sales Value (2019-2030)

1.2.2 Global Neuroleptics Sales Volume (2019-2030)

1.2.3 Global Neuroleptics Sales Price (2019-2030)

1.3 Neuroleptics Market Trends & Drivers

1.3.1 Neuroleptics Industry Trends

1.3.2 Neuroleptics Market Drivers & Opportunity

1.3.3 Neuroleptics Market Challenges

1.3.4 Neuroleptics Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Neuroleptics Players Revenue Ranking (2023)

2.2 Global Neuroleptics Revenue by Company (2019-2024)

2.3 Global Neuroleptics Players Sales Volume Ranking (2023)

2.4 Global Neuroleptics Sales Volume by Company Players (2019-2024)

2.5 Global Neuroleptics Average Price by Company (2019-2024)

2.6 Key Manufacturers Neuroleptics Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Neuroleptics Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Neuroleptics

2.9 Neuroleptics Market Competitive Analysis

2.9.1 Neuroleptics Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Neuroleptics Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroleptics as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 First Generation

3.1.2 Second Generation

3.1.3 Third Generation

3.2 Global Neuroleptics Sales Value by Type

3.2.1 Global Neuroleptics Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Neuroleptics Sales Value, by Type (2019-2030)

3.2.3 Global Neuroleptics Sales Value, by Type (%) (2019-2030)

3.3 Global Neuroleptics Sales Volume by Type

3.3.1 Global Neuroleptics Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Neuroleptics Sales Volume, by Type (2019-2030)

3.3.3 Global Neuroleptics Sales Volume, by Type (%) (2019-2030)

3.4 Global Neuroleptics Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Schizophrenia

4.1.2 Bipolar Disorder

4.1.3 Unipolar Depression

4.1.4 Dementia

4.1.5 Others

4.2 Global Neuroleptics Sales Value by Application

4.2.1 Global Neuroleptics Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Neuroleptics Sales Value, by Application (2019-2030)

4.2.3 Global Neuroleptics Sales Value, by Application (%) (2019-2030)

4.3 Global Neuroleptics Sales Volume by Application

4.3.1 Global Neuroleptics Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Neuroleptics Sales Volume, by Application (2019-2030)

4.3.3 Global Neuroleptics Sales Volume, by Application (%) (2019-2030)

4.4 Global Neuroleptics Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Neuroleptics Sales Value by Region

5.1.1 Global Neuroleptics Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Neuroleptics Sales Value by Region (2019-2024)

5.1.3 Global Neuroleptics Sales Value by Region (2025-2030)

5.1.4 Global Neuroleptics Sales Value by Region (%), (2019-2030)

5.2 Global Neuroleptics Sales Volume by Region

5.2.1 Global Neuroleptics Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Neuroleptics Sales Volume by Region (2019-2024)

5.2.3 Global Neuroleptics Sales Volume by Region (2025-2030)

5.2.4 Global Neuroleptics Sales Volume by Region (%), (2019-2030)

5.3 Global Neuroleptics Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Neuroleptics Sales Value, 2019-2030

5.4.2 North America Neuroleptics Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Neuroleptics Sales Value, 2019-2030

5.5.2 Europe Neuroleptics Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Neuroleptics Sales Value, 2019-2030

5.6.2 Asia Pacific Neuroleptics Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Neuroleptics Sales Value, 2019-2030

5.7.2 South America Neuroleptics Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Neuroleptics Sales Value, 2019-2030

5.8.2 Middle East & Africa Neuroleptics Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Neuroleptics Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Neuroleptics Sales Value

6.2.1 Key Countries/Regions Neuroleptics Sales Value, 2019-2030

6.2.2 Key Countries/Regions Neuroleptics Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Neuroleptics Sales Value, 2019-2030

6.3.2 United States Neuroleptics Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Neuroleptics Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Neuroleptics Sales Value, 2019-2030

6.4.2 Europe Neuroleptics Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Neuroleptics Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Neuroleptics Sales Value, 2019-2030

6.5.2 China Neuroleptics Sales Value by Type (%), 2023 VS 2030

6.5.3 China Neuroleptics Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Neuroleptics Sales Value, 2019-2030

6.6.2 Japan Neuroleptics Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Neuroleptics Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Neuroleptics Sales Value, 2019-2030

6.7.2 South Korea Neuroleptics Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Neuroleptics Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Neuroleptics Sales Value, 2019-2030

6.8.2 Southeast Asia Neuroleptics Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Neuroleptics Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Neuroleptics Sales Value, 2019-2030

6.9.2 India Neuroleptics Sales Value by Type (%), 2023 VS 2030

6.9.3 India Neuroleptics Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 Johnson & Johnson

7.1.1 Johnson & Johnson Company Information

7.1.2 Johnson & Johnson Introduction and Business Overview

7.1.3 Johnson & Johnson Neuroleptics Sales, Revenue and Gross Margin (2019-2024)

7.1.4 Johnson & Johnson Neuroleptics Product Offerings

7.1.5 Johnson & Johnson Recent Development

7.2 Pfizer

7.2.1 Pfizer Company Information

7.2.2 Pfizer Introduction and Business Overview

7.2.3 Pfizer Neuroleptics Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Pfizer Neuroleptics Product Offerings

7.2.5 Pfizer Recent Development

7.3 Eli Lilly

7.3.1 Eli Lilly Company Information

7.3.2 Eli Lilly Introduction and Business Overview

7.3.3 Eli Lilly Neuroleptics Sales, Revenue and Gross Margin (2019-2024)

7.3.4 Eli Lilly Neuroleptics Product Offerings

7.3.5 Eli Lilly Recent Development

7.4 Bristol-Myers Squibb

7.4.1 Bristol-Myers Squibb Company Information

7.4.2 Bristol-Myers Squibb Introduction and Business Overview

7.4.3 Bristol-Myers Squibb Neuroleptics Sales, Revenue and Gross Margin (2019-2024)

7.4.4 Bristol-Myers Squibb Neuroleptics Product Offerings

7.4.5 Bristol-Myers Squibb Recent Development

7.5 AstraZeneca

7.5.1 AstraZeneca Company Information

7.5.2 AstraZeneca Introduction and Business Overview

7.5.3 AstraZeneca Neuroleptics Sales, Revenue and Gross Margin (2019-2024)

7.5.4 AstraZeneca Neuroleptics Product Offerings

7.5.5 AstraZeneca Recent Development

7.6 GSK

7.6.1 GSK Company Information

7.6.2 GSK Introduction and Business Overview

7.6.3 GSK Neuroleptics Sales, Revenue and Gross Margin (2019-2024)

7.6.4 GSK Neuroleptics Product Offerings

7.6.5 GSK Recent Development

7.7 Allergan

7.7.1 Allergan Company Information

7.7.2 Allergan Introduction and Business Overview

7.7.3 Allergan Neuroleptics Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Allergan Neuroleptics Product Offerings

7.7.5 Allergan Recent Development

8 Industry Chain Analysis

8.1 Neuroleptics Industrial Chain

8.2 Neuroleptics Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Neuroleptics Sales Model

8.5.2 Sales Channel

8.5.3 Neuroleptics Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Johnson & Johnson

Pfizer Inc

Eli Lilly

Bristol–Myers Squibb

Astrazeneca plc

GSK

Allergan plc

List of Tables

Table 1. Neuroleptics Market Trends

Table 2. Neuroleptics Market Drivers & Opportunity

Table 3. Neuroleptics Market Challenges

Table 4. Neuroleptics Market Restraints

Table 5. Global Neuroleptics Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Neuroleptics Revenue Market Share by Company (2019-2024)

Table 7. Global Neuroleptics Sales Volume by Company (2019-2024) & (K MT)

Table 8. Global Neuroleptics Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Neuroleptics Price by Company (2019-2024) & (USD/MT)

Table 10. Key Manufacturers Neuroleptics Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Neuroleptics Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Neuroleptics

Table 13. Global Neuroleptics Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroleptics as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Neuroleptics Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Neuroleptics Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Neuroleptics Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Neuroleptics Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Neuroleptics Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Neuroleptics Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)

Table 22. Global Neuroleptics Sales Volume by Type (2019-2024) & (K MT)

Table 23. Global Neuroleptics Sales Volume by Type (2025-2030) & (K MT)

Table 24. Global Neuroleptics Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Neuroleptics Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Neuroleptics Price by Type (2019-2024) & (USD/MT)

Table 27. Global Neuroleptics Price by Type (2025-2030) & (USD/MT)

Table 28. Global Neuroleptics Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Neuroleptics Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Neuroleptics Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Neuroleptics Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Neuroleptics Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Neuroleptics Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)

Table 34. Global Neuroleptics Sales Volume by Application (2019-2024) & (K MT)

Table 35. Global Neuroleptics Sales Volume by Application (2025-2030) & (K MT)

Table 36. Global Neuroleptics Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Neuroleptics Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Neuroleptics Price by Application (2019-2024) & (USD/MT)

Table 39. Global Neuroleptics Price by Application (2025-2030) & (USD/MT)

Table 40. Global Neuroleptics Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Neuroleptics Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Neuroleptics Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Neuroleptics Sales Value by Region (2019-2024) & (%)

Table 44. Global Neuroleptics Sales Value by Region (2025-2030) & (%)

Table 45. Global Neuroleptics Sales Volume by Region (K MT): 2019 VS 2023 VS 2030

Table 46. Global Neuroleptics Sales Volume by Region (2019-2024) & (K MT)

Table 47. Global Neuroleptics Sales Volume by Region (2025-2030) & (K MT)

Table 48. Global Neuroleptics Sales Volume by Region (2019-2024) & (%)

Table 49. Global Neuroleptics Sales Volume by Region (2025-2030) & (%)

Table 50. Global Neuroleptics Average Price by Region (2019-2024) & (USD/MT)

Table 51. Global Neuroleptics Average Price by Region (2025-2030) & (USD/MT)

Table 52. Key Countries/Regions Neuroleptics Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Neuroleptics Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Neuroleptics Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Neuroleptics Sales Volume, (2019-2024) & (K MT)

Table 56. Key Countries/Regions Neuroleptics Sales Volume, (2025-2030) & (K MT)

Table 57. Johnson & Johnson Company Information

Table 58. Johnson & Johnson Introduction and Business Overview

Table 59. Johnson & Johnson Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 60. Johnson & Johnson Neuroleptics Product Offerings

Table 61. Johnson & Johnson Recent Development

Table 62. Pfizer Company Information

Table 63. Pfizer Introduction and Business Overview

Table 64. Pfizer Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 65. Pfizer Neuroleptics Product Offerings

Table 66. Pfizer Recent Development

Table 67. Eli Lilly Company Information

Table 68. Eli Lilly Introduction and Business Overview

Table 69. Eli Lilly Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 70. Eli Lilly Neuroleptics Product Offerings

Table 71. Eli Lilly Recent Development

Table 72. Bristol-Myers Squibb Company Information

Table 73. Bristol-Myers Squibb Introduction and Business Overview

Table 74. Bristol-Myers Squibb Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 75. Bristol-Myers Squibb Neuroleptics Product Offerings

Table 76. Bristol-Myers Squibb Recent Development

Table 77. AstraZeneca Company Information

Table 78. AstraZeneca Introduction and Business Overview

Table 79. AstraZeneca Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 80. AstraZeneca Neuroleptics Product Offerings

Table 81. AstraZeneca Recent Development

Table 82. GSK Company Information

Table 83. GSK Introduction and Business Overview

Table 84. GSK Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 85. GSK Neuroleptics Product Offerings

Table 86. GSK Recent Development

Table 87. Allergan Company Information

Table 88. Allergan Introduction and Business Overview

Table 89. Allergan Neuroleptics Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)

Table 90. Allergan Neuroleptics Product Offerings

Table 91. Allergan Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Neuroleptics Downstream Customers

Table 95. Neuroleptics Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Neuroleptics Product Picture

Figure 2. Global Neuroleptics Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Neuroleptics Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Neuroleptics Sales Volume (2019-2030) & (K MT)

Figure 5. Global Neuroleptics Sales Price (2019-2030) & (USD/MT)

Figure 6. Neuroleptics Report Years Considered

Figure 7. Global Neuroleptics Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Neuroleptics Players Sales Volume Ranking (2023) & (K MT)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Neuroleptics Revenue in 2023

Figure 10. Neuroleptics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. First Generation Picture

Figure 12. Second Generation Picture

Figure 13. Third Generation Picture

Figure 14. Global Neuroleptics Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 15. Global Neuroleptics Sales Value Market Share by Type, 2023 & 2030

Figure 16. Global Neuroleptics Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)

Figure 17. Global Neuroleptics Sales Volume Market Share by Type, 2023 & 2030

Figure 18. Global Neuroleptics Price by Type (2019-2030) & (USD/MT)

Figure 19. Product Picture of Schizophrenia

Figure 20. Product Picture of Bipolar Disorder

Figure 21. Product Picture of Unipolar Depression

Figure 22. Product Picture of Dementia

Figure 23. Product Picture of Others

Figure 24. Global Neuroleptics Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 25. Global Neuroleptics Sales Value Market Share by Application, 2023 & 2030

Figure 26. Global Neuroleptics Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)

Figure 27. Global Neuroleptics Sales Volume Market Share by Application, 2023 & 2030

Figure 28. Global Neuroleptics Price by Application (2019-2030) & (USD/MT)

Figure 29. North America Neuroleptics Sales Value (2019-2030) & (US$ Million)

Figure 30. North America Neuroleptics Sales Value by Country (%), 2023 VS 2030

Figure 31. Europe Neuroleptics Sales Value (2019-2030) & (US$ Million)

Figure 32. Europe Neuroleptics Sales Value by Country (%), 2023 VS 2030

Figure 33. Asia Pacific Neuroleptics Sales Value (2019-2030) & (US$ Million)

Figure 34. Asia Pacific Neuroleptics Sales Value by Country (%), 2023 VS 2030

Figure 35. South America Neuroleptics Sales Value (2019-2030) & (US$ Million)

Figure 36. South America Neuroleptics Sales Value by Country (%), 2023 VS 2030

Figure 37. Middle East & Africa Neuroleptics Sales Value (2019-2030) & (US$ Million)

Figure 38. Middle East & Africa Neuroleptics Sales Value by Country (%), 2023 VS 2030

Figure 39. Key Countries/Regions Neuroleptics Sales Value (%), (2019-2030)

Figure 40. Key Countries/Regions Neuroleptics Sales Volume (%), (2019-2030)

Figure 41. United States Neuroleptics Sales Value, (2019-2030) & (US$ Million)

Figure 42. United States Neuroleptics Sales Value by Type (%), 2023 VS 2030

Figure 43. United States Neuroleptics Sales Value by Application (%), 2023 VS 2030

Figure 44. Europe Neuroleptics Sales Value, (2019-2030) & (US$ Million)

Figure 45. Europe Neuroleptics Sales Value by Type (%), 2023 VS 2030

Figure 46. Europe Neuroleptics Sales Value by Application (%), 2023 VS 2030

Figure 47. China Neuroleptics Sales Value, (2019-2030) & (US$ Million)

Figure 48. China Neuroleptics Sales Value by Type (%), 2023 VS 2030

Figure 49. China Neuroleptics Sales Value by Application (%), 2023 VS 2030

Figure 50. Japan Neuroleptics Sales Value, (2019-2030) & (US$ Million)

Figure 51. Japan Neuroleptics Sales Value by Type (%), 2023 VS 2030

Figure 52. Japan Neuroleptics Sales Value by Application (%), 2023 VS 2030

Figure 53. South Korea Neuroleptics Sales Value, (2019-2030) & (US$ Million)

Figure 54. South Korea Neuroleptics Sales Value by Type (%), 2023 VS 2030

Figure 55. South Korea Neuroleptics Sales Value by Application (%), 2023 VS 2030

Figure 56. Southeast Asia Neuroleptics Sales Value, (2019-2030) & (US$ Million)

Figure 57. Southeast Asia Neuroleptics Sales Value by Type (%), 2023 VS 2030

Figure 58. Southeast Asia Neuroleptics Sales Value by Application (%), 2023 VS 2030

Figure 59. India Neuroleptics Sales Value, (2019-2030) & (US$ Million)

Figure 60. India Neuroleptics Sales Value by Type (%), 2023 VS 2030

Figure 61. India Neuroleptics Sales Value by Application (%), 2023 VS 2030

Figure 62. Neuroleptics Industrial Chain

Figure 63. Neuroleptics Manufacturing Cost Structure

Figure 64. Channels of Distribution (Direct Sales, and Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Neuroleptic Market Research Report 2025

Psychiatric Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antipsychotic Medications Market Research Report 2024

Psychotropic Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long acting Antipsychotic Market Research Report 2024

Global Antipsychotic Drug Market Research Report 2024

Iloperidone Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Long Acting Schizophrenia Drug Market Research Report 2024

Global Atypical Antipsychotic Drugs Market Insights Forecast to 2030

Global Anti schizophrenic Drugs Market Research Report 2025

Lithium Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Psychiatric Medication Therapies Market Research Report 2024

Long Acting Injectable LAI Antipsychotic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Psychiatric and Nervous Drugs Market Research Report 2025

Mental Disorders Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Haloperidol Market Research Report 2024

Drugs for Treating Mental Disorders Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Bipolar Disorders and Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Long acting Injectable Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions